Bausch + Lomb lifted its full-year targets after narrowing its second-quarter loss as its core segments drove revenue higher. The dual Toronto and New York-listed eye health company on Wednesday raised its full-year guidance across the board.

The company bumped its revenue target up by $20 million to a new range of $5.44 billion to $5.54 billion. The increase would represent 5.8% to 7.7% constant currency growth.

Alongside the new revenue target, the company lifted its full-year adjusted earnings before interest, taxes, depreciation and amortization expectation by $15 million at the high and low ends of the range, to between $1.025 billion and $1.075 billion.

Foreign exchange tailwinds have also moderated, and the company now expects them at $45 million, instead of $50 million. For the second quarter, the company posted a narrowed net loss of $14 million.